Zusammenfassung
Hauptursache der frühen Morbidität und Mortalität nach Lungentransplantation ist das primäre Transplantatversagen hervorgerufen durch einen Ischämie-Reperfusions-Schaden. Am Modell der allogenen orthotopen unilateralen Lungentransplantation am Schwein haben wir den Einfluß der Lungenkonservierung mit Euro Collins- oder Low-Potassium-Dextran (LPD) Lösung auf den Ischämie-Reperfusions-Schaden und die Aktivierung neutrophiler Granulozyten (PMN) untersucht. Spender- und Empfängertiere wurden in 3 experimentelle Gruppen randomisiert. EC-Gruppe (n=6): In situ Flush-Perfusion mit modifizierter Euro-Collins (EC) Lösung: EC+PTX-Gruppe (n=6): Perfusion mit EC unter Zusatz von Pentoxifyllin (300 mg/l) zur Inhibierung der Leukozytenaktivierung; LPD-Gruppe (n=6): Flush-Perfusion mit LPD (Perfadex) Lösung (100 ml/kg). Nach 18 h Ischämie (4 °C) wurde eine linksseitige unilaterale Transplantation durchgeführt und während 6 h Reperfusion die Lungenfunktion gemessen. Der oxidative Lungenschaden, quantifiziert anhand der Lipidperoxidation (Thiobarbitursäure-reaktive Substanzen (TBARM) in der bronchoalveolären Lavage) und die Ausbildung eines Lungenödems, gemessen als Lungenfeucht/Lungentrockengewichts-Verhältnis (W/D ratio) am Ende der 6stündigen Reperfusion waren sowohl in der EC+PTX als auch in der LPD-Gruppe signifikant geringer als in der EC-Gruppe. Die Transplantatfunktion (arterieller PO2) war signifikant besser bei EC+PTX-konservierten Lungen als nach EC-Konservierung. Wir schließen aus unseren Ergebnissen: (1) Die Aktivierung neutrophiler Granulozyten spielt eine zentrale Rolle für die Ausbildung eines Ischämie-Reperfusions-Schadens nach Lungentransplantation. (2) Lungenkonservierung mit LPD-(Perfadex) Lösung resultiert in einer verminderten Leukozytenaktivierung und einem geringeren Ischämie-Reperfusions-Schaden nach Lungentransplantation.
Summary
The impact of pulmonary vascular flush preservation with Eurocollin’s (EC) solution or low-potassium-dextran (LPD) solution (Perfadex®) on ischemia reperfusion-injury after lung transplantation and the contribution of PMN leukocytes were assessed in an animal model of left-sided orthotopic single lung transplantation. Eighteen pairs of domestic pigs were randomized into three experimental groups: In the EC group (n=6) donor lungs were in situ flush perfused with modified EC solution; in the EC+PTX group (n=6), 300 mg/l of pentoxifylline (PTX) was added to the EC flush solution, and 12 mg/kg of PTX were injected intravenously shortly before reperfusion to inhibit PMN activation; in the LPD group (n=6) low potassium dextran solution (Perfadex®, 100 ml/kg) was used for flush. The duration of cold lung storage was 18 hours. After reimplantation recipient animals were monitored during 6 h of reperfusion. Lung oxidant injury, as evidenced by increased lung wet/dry weight ratios (p<0.05, ANOVA), and lung lipid peroxidation (p<0.01), and PMN accumulation in broncho-alveolar lavage (BAL) fluids (p<0.05) during reperfusion were lower in both the EC+PTX and LPD groups as compared to the EC group. This was paralleled by significantly improved graft function (PaO2) in both the EC+PTX and LPD groups as compared to the EC group (p<0.05). In summary, our results showed that (1) PMN contribute significantly to lung injury during reperfusion following ischemia and lung transplantation, and (2) LPD-preserved lungs as compared to EC-preserved lungs show reduced PMN activation and better early graft function after lung transplantation. Our results suggest that the use of LPD-flush perfusion for lung preservation may result in a reduced incidence of lung ischemia-reperfusion injury after lung transplantation.
Literatur
Al-Khalidi UAS, Chaglassian TH (1965) The species distribution of xanthine oxidase. Biochem J 97: 318–320
Aziz S, Suzuki K, Rice G, Reichenbach DD (1996) Prolongation of discordant cardiac xenotransplantation survival by Lisofylline, a phosphatidic acid inhibitor. Transplant Proc 28: 740
Breda MA, Hall TS, Stuart RS (1985) Twenty-four hour lung preservation by hypothermia and leukocyte depletion. J Heart Transpl 4: 325–329
Chapelier A, Reignier J, Mazmanian M, Dulmet E, Libert JM, Dartevelle P, Barbotin F, Herve P (1995) Amelioration of reperfusion injury by pentoxfylline after lung transplantation. The Universite Paris-Sud Lung Transplant Group. J Heart Lung Transplant 14: 676–683
Cooper JD, Vreim CE (1992) NHLBI workshop summary. Biology of lung preservation for transplantation. Am Rev Respir Dis 146: 803–807
Cooper JD (1996) St. Louis International Lung Transplant Registry — April 1996 Report
Hammerschmidt DE, Kotasek D, McCarthy T, Huh PW, Freyburger G, Vercellotti GM (1988) Pentoxifylline inhibits granulocyte and platelet function, including granulocyte priming by platelat activating factor. J Lab Clin Med 112: 254–263
Kennedy TP, Rao NV, Hopkins C, Pennigton L, Tolley E, Hoidal JR (1989) Role of reactive oxygen species in reperfusion injury in the rabbit lung. J Clin Invest 83: 1326–1335
Matsuzaki Y, Waddell TK, Puskas JD, Hirai T, Nakajima S, Slutsky AS, Patterson GA (1993) Amelioration of postischemic lung reperfusion injury by prostaglandin E1. Am Rev Respir Dis 148: 882–889
Novick RJ, Menkis AH, McKenzie FN (1992) New trends in lung preservation: a collective review. J Heart Lung Transplant 11: 377–392
Okabayashi K, Aoe M, De Meester SR, Cooper JD, Patterson GA (1994) Pentoxifylline reduces lung allograft reperfusion injury. Ann Thorac Surg 58: 50–56
Oosterhoff Y, Noordhek JA, Petersen AH, Kauffman HF, Postma DS, Prop J (1992) There is no activation of O2-production by alveolar macrophages and neutrophil polymorphonuclear leukocytes in rat lung transplants during the reimplantation response and acute rejection. Am Rev Respir Dis 145: 1155–1159
Paull DE, Keagy BA, Kron EJ, Wilcox BR (1989) Reperfusion injury in the lung preserved for 24 hours. Ann Thorac Surg 47: 187–192
Puskas JD, Cardoso PF, Mayer E, Shi S, Slutsky AS, Patterson GA (1992) Equivalent eighteen-hour lung preservation with low-potassium dextran or Euro-Collins solution after prostaglandin E1 infusion. J Thorac Cardiovasc Surg 104: 83–89
Shi Y, Kornovski BS, Savani R, Turley EA (1993) A rapid, multiwell colorimetric assay for chemotaxis. J Immunol Method 164: 149–154
Steen S, Kimblad PO, Sjöberg T, Lindberg L, Ingemansson R, Massa G (1994) Safe lung preservation for twenty-four hours with Perfadex. Ann Thorac Surg 57: 450–457
Steen S, Sjöberg T, Massa G, Ericsson L, Lindberg L (1993) Safe pulmonary preservation for 12 hours with low-potassium-dextran solution. Ann Thorac Surg 55: 434–440
Steimle CN, Guynn TP, Morganroth ML, Bolling SF, Carr K, Deeb GM (1992) Neutrophils are not necessary for ischemia-reperfusion lung injury. Ann Thorac Surg 53: 64–72
Takeda K, Shimada Y, Amano M, Sakai T, Okada T, Yoshida I (1984) Plasma lipidperoxides and alpha-tocopherol in critical ill patients. Crit Care Med 12: 957–959
Wang LS, Nakamoto K, Hsieh CM, Miyoshi S, Cooper JD (1993) Influence of temperature of flushing solution on lung preservation. Ann Thorac Surg 55: 711–715
Xiong L, Mazmanian M, Chapelier AR et al. (1994) Lung preservation with Euro-Collins, University of Wisconsin, Wallwork, and low-potassium-dextran solution. University Paris-Sud Lung Transplant Group. Ann Thorac Surg 58: 845–850
Yamashita M, Schmid RA, Okabayashi K, Patterson GA (1996) Pentoxifylline in flush solution improves early lung allograft function. Ann Thorac Surg 61: 1055–1061
Yonemaru M, Hatherill JR, Hoffmann H, Zheng H, Ishii K, Raffin TA (1991) Pentoxifylline does not attenuate acute lung injury in the absence of granulocytes. J Appl Physiol 71: 342–351
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Hoffmann, H., Müller, C., Sakamaki, F. et al. Aktivierung neutrophiler Granulozyten während Ischämie der Lunge und Reperfusion nach Transplantation: Effekt der Konservierungslösungen Euro-Collins und Low-Potassium-Dextran. Z. Herz-, Thorax-, Gefäßchir. 11, 108–114 (1997). https://doi.org/10.1007/BF03042633
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF03042633
Schlüsselwörter
- Lungentransplantation
- Neutrophile Granulozyten (PMN)
- Euro Collins-Lösung
- Low-Potassium-Dextran-Lösung
- Pentoxifyllin